THE FUTURE OF LUXURY REAL ESTATE IS GOING GLOBAL! EXP LUXURY LAUNCHES IN AUSTRALIA, NEW ZEALAND, SOUTH AFRICA AND THE UNITED KINGDOM

BELLINGHAM, Wash., Dec 8 (Bernama-GLOBE NEWSWIRE) -- eXp Realty, "the most agent-centric real estate brokerage on the planet™" and a core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), proudly announces the continued expansion of its luxury real estate program, eXp Luxury, into the dynamic international markets of Australia, New Zealand, South Africa and the United Kingdom.

Having built an impressive 1,100 members and counting across the United States, Canada, and Puerto Rico over the last fifteen months, eXp Luxury continues its exponential growth trajectory. The program made its debut in the United States in October 2022, followed by a launch in Canada in September 2023 and most recently, it extended its reach to Puerto Rico, further expanding its presence.

The remarkable success and high demand for eXp Luxury have paved the way for this launch into new international territories, providing eXp Realty Luxury agents unrivaled access to extraordinary investment opportunities. With memberships that provide the ability to showcase remarkable listing campaigns through exclusive partnerships, elevate brand aesthetics through a bespoke design center, and foster growth through robust learning events and vibrant networking opportunities, agents can truly thrive in luxury real estate.

“eXp Luxury represents our dedication to empowering elite real estate professionals with unparalleled tools and resources to enhance production and strengthen their individual brands while elevating their customer service offerings,” says Michael Valdes, Chief Growth Officer at eXp Realty. "This strategic international expansion marks a pivotal moment, showcasing eXp Realty's unwavering commitment to not only revolutionizing the global real estate landscape but setting a new benchmark for excellence in luxury real estate."

For more about the eXp Luxury program, visit expluxury.com.

About eXp World Holdings, Inc.

eXp World Holdings, Inc. (Nasdaq: EXPI) is the holding company for eXp Realty^®, Virbela^® and SUCCESS^® Enterprises.

eXp Realty is the largest independent real estate company in the world with more than 89,000 agents in the United States, Canada, the United Kingdom, Australia, South Africa, India, Mexico, Portugal, France, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Panama, Germany, Dominican Republic, Greece, New Zealand, Chile, Poland and Dubai and continues to scale internationally. As a publicly traded company, eXp World Holdings provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. eXp World Holdings and its businesses offer a full suite of brokerage and real estate tech solutions, including its innovative residential and commercial brokerage model, professional services, collaborative tools and personal development. The cloud-based brokerage is powered by Virbela, an immersive 3D platform that is deeply social and collaborative, enabling agents to be more connected and productive. SUCCESS^® Enterprises, anchored by SUCCESS^® magazine and its related media properties, was established in 1897 and is a leading personal and professional development brand and publication.

For more information, visit https://expworldholdings.com.    

Safe Harbor Statement

The statements contained herein may include statements of future expectations and other forward-looking statements that are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Such forward-looking statements speak only as of the date hereof, and the company undertakes no obligation to revise or update them. Such statements are not guarantees of future performance. Important factors that may cause actual results to differ materially and adversely from those expressed in forward-looking statements include changes in business or other market conditions; the difficulty of keeping expense growth at modest levels while increasing revenues; and other risks detailed from time to time in the company’s Securities and Exchange Commission filings, including but not limited to the most recently filed Quarterly Report on Form 10-Q and Annual Report on Form 10-K. 

http://mrem.bernama.com/viewsm.php?idm=47732

INTERNATIONAL DIRECTIONAL SERVICES AND VERACIO ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE DRILLING AND DOWNHOLE TECHNOLOGIES IN NORTH AMERICA

 WATSONVILLE, Calif. and SALT LAKE CITY, Dec 7 (Bernama-GLOBE NEWSWIRE) -- International Directional Services (IDS), a Granite Company (NYSE:GVA) and Veracio, a leading mining technology company, today announce a partnership to offer Veracio’s complete suite of driller-operated tooling to IDS’ clients.

Veracio is making significant steps toward leveraging advanced geological technologies to enhance the mining lifecycle. While IDS and Veracio have an existing relationship, the announcement of this partnership acknowledges the vision both companies share for transforming how the drilling workflow can be enhanced with better data. By combining IDS’s expertise in directional drilling and Veracio’s geological data collection, the partnership will empower IDS and Granite clients to reduce unnecessary drilling costs, mitigate operational errors, minimize waste, and foster sustainable mining practices.

“Our collaboration further strengthens Veracio’s position in the US market and reinforces our commitment to advancing the mining industry by offering cutting-edge solutions,” states Veracio’s Chief Executive Officer, JT Clark. “Together with IDS, we are committed to redefining industry standards, empowering precision and integrity with every survey, and delivering unparalleled solutions for the mining industry.”

"We are excited to embark on this strategic partnership with Veracio. By combining our data collection expertise with Veracio’s cutting-edge instrument technology, we aim to redefine how drill hole data is utilized in our industry,” said Jason Smith, IDS General Manager. “This collaboration represents a significant step forward for IDS and our commitment to delivering excellence to our clients."

Key Objectives of the Partnership:

• Enhanced Drill Hole Data Analysis: Deploy cutting-edge technology to enhance the accuracy and quality of drill hole data analysis, providing valuable insights for mining projects.
• Increased Productivity: Leveraging Veracio’s growing fleet of technologies, including TruGyro, and TruSub technology ensures that drilling is precise and efficient leading to better resource definition, safety and lower risks of operational errors, at lower cost.
• Client Support and Satisfaction: The partnership aims to elevate the level of support and satisfaction for IDS’s clients by delivering data-driven insights and innovative solutions.

The announcement is headlined by the most compact and integrated continuous north-seeking gyro tool in drilling, Veracio’s TruGyro, a north-seeking gyro tool built to deliver precision data at depth in some of the toughest of environments. IDS also currently serves as the distributor for Veracio’s TruShot, a precise magnetic survey tool specially designed for driller deployment. Known for its durability, precision, and user-friendly features, TruShot enables drillers to confidently capture high-quality 3D hole path data. In addition to TruShot, IDS also distributes core orientation tooling on behalf of Veracio. As Veracio introduces new products to the market, IDS aims to expand its customer offerings to provide a comprehensive range of cutting-edge solutions.

Photos accompanying this announcement are available at - 
https://drive.google.com/drive/folders/1AZcrwz8G6Ii4AveB6WDOrHozAgvx7-QY?usp=drive_link

About Veracio
Veracio offers mining clients a range of solutions that improve, automate, and digitally transform their orebody sciences in exploration, resource definition and production. Championing a modern approach through a diverse product portfolio Veracio fuses science and technology together with digital accessibility by using advanced scanning, sensing with strong data governance and the deployment of AI to accelerate real-time decision making and significantly improve efficiency, profitability, and sustainability across the value chain. For more information about Veracio, please visit www.veracio.com.

About Granite
Granite is America’s Infrastructure Company™. Incorporated since 1922, Granite (NYSE: GVA) is one of the largest diversified construction and construction materials companies in the United States as well as a full-suite civil construction provider. Granite’s Code of Conduct and strong Core Values guide the Company and its employees to uphold the highest ethical standards. Granite is an industry leader in safety and an award-winning firm in quality and sustainability. For more information, visit the Granite website, graniteconstruction.com, and connect with Granite on LinkedIn, X, Facebook, and Instagram.

Media Contacts
 

Veracio        

Kamran Shaikh

PRA Communications

kshaikh@pracommunications.com

Cell: +1-778-846-5406

 

IDS/Granite

Erin Kuhlman - 831-768-4111

Investors

Wenjun Xu - 831-761-7861

SOURCE: Veracio

--BERNAMA

INTERNATIONAL SCIENCE ORGANIZATIONS SIGN AGREEMENT TO PROVIDE HARDWARE FOR THE DEEP UNDERGROUND NEUTRINO EXPERIMENT

Ten international funding agencies will contribute to the construction of the gigantic particle detectors a mile underground for the Fermilab-hosted Deep Underground Neutrino Experiment.

Batavia, Illinois, Dec 7 (Bernama-GLOBE NEWSWIRE) -- The Deep Underground Neutrino Experiment — also known as DUNE — is an international mega science experiment that will use enormous particle detectors to study the behavior of neutrinos, which might indicate why we live in a matter-dominated universe.

The DUNE collaboration, representing scientists from dozens of countries around the world, will contribute to the construction of detectors at two sites in the United States: one at the U.S. Department of Energy’s Fermi National Accelerator Laboratory, the host lab for DUNE, 40 miles west of Chicago, and the other at the Sanford Underground Research Laboratory (SURF) in Lead, South Dakota.

On Nov. 17, representatives of funding agencies from five countries signed a memorandum of understanding, affirming their commitment to contribute to the construction of components for DUNE. Director Lia Merminga signed on behalf of Fermilab.

“DUNE will help answer some of the biggest questions in the universe and has the potential to transform the field of neutrino physics. We are proud to host DUNE in the U.S. with major contributions from the project’s international partners who offer their unique expertise,” said Regina Rameika, DOE associate director for the Office of High Energy Physics. “Having the commitment from our international partners to contribute these vital components is an essential aspect of DUNE.”

With their signatures, University of Campinas (Unicamp), Brazil, Institut National de Physique Nucléaire et de Physique des Particules (IN2P3), France, Istituto Nazionale Di Fisica Nucleare (INFN), Italy, University of Bern, Switzerland, and the Science and Technology Facilities Council/United Kingdom Research and Innovation (STFC/UKRI), United Kingdom, committed to contributing hardware to the two DUNE Far Detectors in South Dakota.

The Canadian Foundation for Innovation John R. Evans Leaders Fund and the Ontario Research Fund in Canada in addition to CERN in Switzerland also signed the memorandum of understanding remotely and will contribute to the DUNE Near Detector in Batavia, Illinois.

Signatures from agencies in the Czech Republic and Spain have been coordinated and will be finalized in the future.

In the memorandum of understanding for Far Detector 1, the United Kingdom and CERN agreed to contribute to anode plane assemblies; Brazil, the Czech Republic, Italy and Spain will contribute to the photon detection system; CERN will contribute to the high-voltage system; Canada, CERN and the U.K. will contribute to the data acquisition system; and Spain will contribute to the calibration and cryogenics instrumentation.

In the memorandum of understanding for Far Detector 2, CERN and France agreed to contribute to top drift electronics; Brazil, the Czech Republic, France, Italy and Spain will contribute to the photon detection system; France and CERN will contribute to the high-voltage system; Canada, CERN and the U.K. will contribute to the data acquisition system; Spain will contribute to the calibration and cryogenics instrumentation; and CERN and France will contribute to the charge readout planes.

Scientists and engineers from more than 35 countries are partnering with Fermilab to design, build and analyze data from DUNE, which will be installed in the new Long-Baseline Neutrino Facility. Construction of LBNF has begun, and the excavation of the large caverns in Lead, South Dakota for the DUNE Far Detectors is more than 85% complete.

The DUNE collaboration comprises more than 1,400 scientists and engineers from over 200 research institutions. Notably, CERN’s commitment to LBNF and DUNE represents its first investment in infrastructure for a physics experiment outside of Europe. Several countries — France, India, Italy, Poland and the United Kingdom — also are making significant contributions to the Proton Improvement Plan II project, which includes the construction of the 215-meter-long superconducting particle accelerator at Fermilab that will power DUNE.

DUNE will be the world’s most comprehensive experiment to study neutrinos: tiny, lightweight particles that permeate the universe but rarely interact with anything. DUNE will seek to determine whether neutrinos could be the reason the universe is made of matter; look for neutrinos emitted from exploding stars to learn more about the formation of neutron stars and black holes; and watch for a rare subatomic phenomenon that could elucidate the unification of nature’s forces.

To pursue these science goals, DUNE will study neutrino oscillation, a phenomenon in which a neutrino’s property, called flavor, changes as it travels. DUNE will probe this oscillation by shooting a beam of neutrinos 1,300 kilometers straight through the earth, from Fermilab’s accelerator complex in Illinois, through the Near Detector to the Far Detectors located a mile underground at SURF in South Dakota.

The science of DUNE is a global endeavor, and the partnership with funding agencies, scientists and engineers from around the world makes it the first truly international mega science experiment to be hosted on U.S. soil. Additionally, hundreds of students from all corners of the earth will start their careers in science, engineering and computing on this project.

Fermi National Accelerator Laboratory is supported by the Office of Science of the U.S. Department of Energy. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov. 

http://mrem.bernama.com/viewsm.php?idm=47720

CURIA RECOGNIZED ON INDIA PHARMA OUTLOOK’S 2023 LIST OF TOP 10 CDMO COMPANIES IN INDIA

ALBANY, N.Y., Dec 6 (Bernama-GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced it has been recognized as one of the top 10 CDMOs in India by India Pharma Outlook. The full list can be viewed in the November 2023 edition of the India Pharma Outlook magazine.

This recognition acknowledges the contributions of Curia’s Aurangabad and Hyderabad sites. The Aurangabad facility provides contract manufacturing of active pharmaceutical ingredients (APIs) and intermediates, and the Hyderabad site includes the Hyderabad Research Center with expertise in medicinal chemistry and chemical and analytical development. These sites also house Curia’s quality control center and Global Shared Services (GSS) center, which support the company’s global organization, enabling process standardization and scalability.

Curia’s focus on continuous improvement for its comprehensive suite of services and investments in innovative technologies position the company as a strong partner to pharmaceutical and biotechnology companies across the drug research, development and manufacturing continuum. The report also highlights Curia’s commitment to being an employer of choice, providing employees with a workplace culture rich in opportunities for professional development and recognition.

“This achievement is a testament to the talent and hard work from our Aurangabad and Hyderabad facilities, and it is a well-deserved honor for the team,” said Philip Macnabb, CEO, Curia. “Our India sites relentlessly pursue excellence and are vital to our goal of improving patients’ lives.”

India Pharma Outlook’s editorial board compiled the list with a panel of judges with expertise in the industry, including CXOs and analysts. Winners were chosen for their impact on India’s economy through job creation, fostering research and development and for their high-quality offerings in the pharmaceutical and biotechnology industry.

About Curia
Curia is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s nearly 4,000 employees at 27 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

A PDF accompanying this announcement is available at: 
http://ml.globenewswire.com/Resource/Download/faac19ea-f26f-4811-946f-e03d10480984

SOURCE: Curia Global, Inc.

--BERNAMA

RXCELL ANNOUNCES $4,600,000 INVESTMENT FROM DMR GLOBAL VENTURE AND REGENOSIS, PLANS FOR SECOND RAISE OF $15,000,000 FOR IND TESTING IN Q4 2023

SINGAPORE, Dec 6 (Bernama-BUSINESS WIRE) -- RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment from DMR Global Venture LLC and Regenosis. Building on the strength of collaboration with National University of Singapore, this fresh investment accentuates RxCell’s resolute drive to revolutionize age-related disease treatment.

Furthermore, RxCell is gearing up for a substantial second capital raise of $15,000,000 in Q4 2023. This upcoming fundraise is strategically designed to secure the necessary resources, propelling the company forward through its promising IND (Investigational New Drug) application testing and process.

The Market Landscape:

The global Age-related Macular Degeneration (AMD) Market, an integral segment RxCell operates in, had a valuation of USD 7.47 billion in 2021. This market is projected to surge forward at a CAGR of 7.9% from 2021 to 2030.

Contemporary Methods vs. RxCell’s Approach:

Most prevalent methods in the market predominantly focus on slowing or halting the progression of cell death by replacing afflicted cells with RPE (Retinal Pigment Epithelium) or other cell types that introduce trophic factors. However, using RPE replacement alone is believed to offer limited value, especially to patients who have already suffered significant photoreceptor loss.

RxCell stands distinctively apart with its innovative approach. The firm intends to treat patients by replacing damaged or dysfunctional cells with healthy and functional iPSC-derived RPC (photoreceptors). Alternatively, they employ a combination of RPC and RPE with the primary aim of restoring vision. RxCell is determined to demonstrate the broad value of its RPC product in an upcoming Phase I/IIA clinical trial, targeting RP patients.

Professor Xianmin Zeng, CEO of RxCell, remarked, "We're thrilled to align with DMR Global Venture and Regenosis. Their unwavering support invigorates our mission. With the forthcoming capital raise of $15,000,000, we're poised to solidify our position in the AMD market, bringing about transformative therapies that reshape the landscape."

Both DMR Global Venture and Regenosis are recognized names, with the former being a dynamic investment firm focusing on the US healthcare sector and the latter, a Singapore-based entity, devoted to combating the effects of ageing.

In light of prior milestones, including the collaboration with A*STAR’s IMCB, NUS, and SERI, RxCell remains unwavering in its commitment to the biotech ecosystem. This recent capital influx, coupled with the planned Q4 raise, fortifies the company’s commitment to combating age-related diseases.

For details on our esteemed investors:

About RxCell, Inc.

RxCell Inc. is a forerunner in the cell therapy domain, particularly in the therapeutic applications of induced pluripotent stem cells (iPSCs). With cutting-edge solutions such as their patented technology, RxCell is consistently charting new territory in regenerative medicine. Further information can be accessed at https://www.rxcellinc.com/. 

http://mrem.bernama.com/viewsm.php?idm=47707

GENETIC TESTING GENE SOLUTIONS SPEARHEADS IN PROMOTING PREVENTIVE CARE AT ESMO ASIA 2023

HANOI, Vietnam, Dec 6 (Bernama-GLOBE NEWSWIRE) -- Vietnam’s leading genetic testing firm Gene Solutions, specializing in detecting the presence of certain diseases based on their genetic markers, made a remarkable impact at ESMO Asia Congress 2023, one of the most prestigious oncology conferences held in Singapore from December 1 to 3.

ESMO Asia is where distinguished international experts, key opinion leaders, and oncology associations meet annually to present and discuss the latest scientific and clinical advances in oncology in the Asia-Pacific region and the world.

As the only representative of South East Asia at the 2023 congress, Gene Solutions introduced its achievements in Next-generation sequencing (NGS), presenting significant steps forward in personalized medicine in cancer treatment. The research and development team presented five reports, including an oral and four poster presentations that illustrated the clinical advantages of genetic testing for cancer screening and tracking. Two presentations were awarded the Travel Merit Award.

Gene Solutions has made impressive strides in the region, present in Vietnam, Thailand, Philippines, Malaysia, Indonesia, and now Singapore. Its sixth laboratory recently opened in Singapore is a clear indication of the recognition and cooperation from this global powerhouse. It also hosted a meeting with the theme "A One-stop solution for all cancer patients," bringing together experts from six Southeast Asian countries.

Earlier in 2023, Gene Solutions’ clinical research success was recognized at The ASCO Breakthrough in Japan, with two ASCO Breakthrough Abstract Awards. They were selected for a prominent press conference to highlight the exceptional outcomes of their clinical validation study, K-DETEK.

This pioneering company is on a mission to combat these ailments and improve patient care in Southeast Asia. It has developed Screening for the Presence of Tumor by Methylation And Size (SPOT-MAS) - a multimodal liquid biopsy-based assay that can detect the five most common cancer types (liver, breast, colorectal, gastric, lung cancer).

In April 2022, the first analytical validation of SPOT-MAS test was conducted on a cohort of 738 patients, 1550 healthy individuals and published in the esteemed journal, eLife (eLife.89083.2). This proved SPOT-MAS' ability to detect cancer patients with a sensitivity of 72.4% and a specificity of 97.0%. With products like SPOT-MAS, OncoGS, K-TRACK, K-4CARE, Gene Solutions has been at the forefront of applying liquid biopsy technology to support screening, diagnosis, guiding and monitoring treatment for various types of cancer.

Gene Solutions was co-founded in 2017 by Dr. Nguyen Hoai Nghia (CEO), Dr. Nguyen Huu Nguyen (Deputy CEO), and Dr. Giang Hoa (R&D Head). They have strong backgrounds in genetics, cancer biology, clinical medicine, biotechnology.

After studying cancer biology and genetics in the US, Dr. Nghia wished to establish cutting-edge technologies in Vietnam. That was when "Gene Solutions" as an idea came to be. They aim to create a solution that will be more accessible, affordable, and widely accessible, thereby benefiting millions of people in Southeast Asia.

“It was an exciting experience to present our research at this esteemed event for the first time, and an honor to be rewarded for our efforts. We are proud of our six-year journey in Vietnam developing NGS. Gene Solutions is leading a much-needed paradigm shift in healthcare by embracing the most recent developments in genetic research, encouraging preventive care, and motivating people to take control of their health,” said Dr. Nguyen Huu Nguyen. 

http://mrem.bernama.com/viewsm.php?idm=47705

SUB-FORUM THEMED "GUANGZHOU NANSHA JOINS HANDS WITH THE WORLD" SUCCESSFULLY HELD

GUANGZHOU, China, Dec. 6, 2023 /Xinhua-AsiaNet/--

On December 4, the sub-forum themed "Guangzhou Nansha Joins Hands with the World" was successfully held during the 5th World Media Summit. This grand event was attended by domestic leaders in relevant fields, international media representatives, renowned experts, scholars, and entrepreneurs, all of whom have paid close attention to Nansha's development, according to Nansha District People's Government. Focusing on the theme of the summit, guests from both at home and abroad delivered speeches on topics, such as Characteristics, Conservation, and Utilization of China's Marine Ecology, Green Environment and Climate Change, Science & Technology and Industrial Innovation, Green and Beautiful Nansha and the Construction of an Ecological Bay Area, and International Commercial Arbitration. Wei Min, Member of the Standing Committee of the CPC Nansha District Committee and Executive Deputy Head of Nansha District, said in his speech that Nansha has benefited from multiple national support strategies as the only state-level new area in Guangdong Province, the largest area in China (Guangdong) Pilot Free Trade Zone, and the demonstration zone of all-round cooperation among Guangdong, Hong Kong, and Macao. As stressed by Xie Peng, Vice Editor-in-Chief of the Outlook Weekly of Xinhua News Agency, the media community should play an active role in promoting international friendship and boosting global development. Nansha should take advantage of the summit to showcase its stance and determination to join hands with the world. Embarking on a new journey, Nansha, at the heart of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), is answering with confidence to worldwide media's questions of the times. With a vibrant momentum, Nansha is attracting more attention from global media and emerging as a new window through which China will show the world its remarkable achievements for modernization and high-quality development.  http://mrem.bernama.com/viewsm.php?idm=47710